{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:11:04Z","timestamp":1791457864913,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":159,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Gu 335\/35-1"],"award-info":[{"award-number":["Gu 335\/35-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2098"],"award-info":[{"award-number":["GRK2098"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1739"],"award-info":[{"award-number":["GRK1739"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AR 376\/12-2"],"award-info":[{"award-number":["AR 376\/12-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1194\/jlr.ra120000682","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T01:44:28Z","timestamp":1583891068000},"page":"896-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro"],"prefix":"10.1016","volume":"61","author":[{"given":"Eyad","family":"Naser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-3275","authenticated-orcid":false,"given":"Fabian","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainelabdeen H.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Hessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Kleuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Arenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin Anne","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Gulbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Carpinteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.RA120000682_bib1","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/sj.onc.1206540","article-title":"Ceramide-mediated clustering is required for CD95-DISC formation","volume":"22","author":"Grassm\u00e9","year":"2003","journal-title":"Oncogene."},{"key":"10.1194\/jlr.RA120000682_bib2","doi-asserted-by":"crossref","unstructured":"Grassm\u00e9, H., V., Jendrossek, A., Riehle, G., von Kurthy, J., Berger, H., Schwarz, M. Weller, R. Kolesnick, and E. Gulbins. 2003. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med., 9: 322\u2013330.","DOI":"10.1038\/nm823"},{"key":"10.1194\/jlr.RA120000682_bib3","doi-asserted-by":"crossref","unstructured":"Herz, J., J., Pardo, H., Kashkar, M., Schramm, E., Kuzmenkina, E., Bos, K. Wiegmann, R. Wallich, P. J. Peters, S. Herzig, . 2009. Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nat. Immunol., 10: 761\u2013768.","DOI":"10.1038\/ni.1757"},{"key":"10.1194\/jlr.RA120000682_bib4","doi-asserted-by":"crossref","unstructured":"Teichgr\u00e4ber, V., M., Ulrich, N., Endlich, J., Riethmuller, B., Wilker, C. C., De Oliveira-Munding, A. M. van Heeckeren, M. L. Barr, G. von K\u00fcrthy, K. W. Schmid, . 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med., 14: 382\u2013391.","DOI":"10.1038\/nm1748"},{"key":"10.1194\/jlr.RA120000682_bib5","doi-asserted-by":"crossref","unstructured":"Gulbins, E., M., Palmada, M., Reichel, A., Luth, C., Bohmer, D., Amato, C. P. M\u00fcller, C. H. Tischbirek, T. W. Groemer, G. Tabatabai, . 2013. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat. Med., 19: 934\u2013938.","DOI":"10.1038\/nm.3214"},{"key":"10.1194\/jlr.RA120000682_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.beem.2014.10.002","article-title":"Types A and B Niemann-Pick disease","volume":"29","author":"Schuchman","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.RA120000682_bib7","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl. Sci. Rare Dis."},{"key":"10.1194\/jlr.RA120000682_bib8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1165\/rcmb.2009-0174OC","article-title":"Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis","volume":"42","author":"Becker","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1194\/jlr.RA120000682_bib9","doi-asserted-by":"crossref","unstructured":"Carpinteiro, A., K. A., Becker, L., Japtok, G., Hessler, S., Keitsch, M., Pozgajova, K. W. Schmid, C. Adams, S. Muller, B. Kleuser, . 2015. Regulation of hematogenous tumor metastasis by acid sphingomyelinase. EMBO Mol. Med., 7: 714\u2013734.","DOI":"10.15252\/emmm.201404571"},{"key":"10.1194\/jlr.RA120000682_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.108.173344","article-title":"Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression","volume":"28","author":"Devlin","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.RA120000682_bib11","doi-asserted-by":"crossref","unstructured":"Chami, M., R., Halmer, L., Schnoeder, K. A., Becker, C., Meier, K., Fassbender, E. Gulbins, and S. Waller. 2017. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PLoS One., 12: e0178622.","DOI":"10.1371\/journal.pone.0178622"},{"key":"10.1194\/jlr.RA120000682_bib12","doi-asserted-by":"crossref","unstructured":"Beckmann, N., K. A., Becker, S., Walter, J. U., Becker, M., Kramer, G., Hessler, S. Weber, J. R. Gothert, K. Fassbender, E. Gulbins, . 2017. Regulation of arthritis severity by the acid sphingomyelinase. Cell. Physiol. Biochem., 43: 1460\u20131471.","DOI":"10.1159\/000481968"},{"key":"10.1194\/jlr.RA120000682_bib13","doi-asserted-by":"crossref","first-page":"12196","DOI":"10.1038\/ncomms12196","article-title":"Crystal structure of mammalian acid sphingomyelinase","volume":"7","author":"Gorelik","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1194\/jlr.RA120000682_bib14","doi-asserted-by":"crossref","unstructured":"Kornhuber, J., M., Muehlbacher, S., Trapp, S., Pechmann, A., Friedl, M., Reichel, C. Muhle, L. Terfloth, T. W. Groemer, G. M. Spitzer, . 2011. Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One., 6: e23852.","DOI":"10.1371\/journal.pone.0023852"},{"key":"10.1194\/jlr.RA120000682_bib15","doi-asserted-by":"crossref","unstructured":"Kornhuber, J., P., Tripal, M., Reichel, C., Muhle, C., Rhein, M., Muehlbacher, T. W. Groemer, and E. Gulbins. 2010. Functional inhibitors of acid sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell. Physiol. Biochem., 26: 9\u201320.","DOI":"10.1159\/000315101"},{"key":"10.1194\/jlr.RA120000682_bib16","unstructured":"Kornhuber, J., P., Tripal, M., Reichel, L., Terfloth, S., Bleich, J., Wiltfang, and E. Gulbins. 2008. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J. Med. Chem., 51: 219\u2013237."},{"key":"10.1194\/jlr.RA120000682_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0014-5793(04)00033-X","article-title":"Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine","volume":"559","author":"K\u00f6lzer","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.RA120000682_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/bchm3.1994.375.7.447","article-title":"The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts","volume":"375","author":"Hurwitz","year":"1994","journal-title":"Biol. Chem. Hoppe Seyler."},{"key":"10.1194\/jlr.RA120000682_bib19","doi-asserted-by":"crossref","unstructured":"Elojeimy, S., D. H., Holman, X., Liu, A., El-Zawahry, M., Villani, J. C., Cheng, A. Mahdy, Y. Zeidan, A. Bielwaska, Y. A. Hannun, . 2006. New insights on the use of desipramine as an inhibitor for acid ceramidase. FEBS Lett., 580: 4751\u20134756.","DOI":"10.1016\/j.febslet.2006.07.071"},{"key":"10.1194\/jlr.RA120000682_bib20","unstructured":"Zeidan, Y. H., B. J., Pettus, S., Elojeimy, T., Taha, L. M., Obeid, T., Kawamori, J. S. Norris, and Y. A. Hannun. 2006. Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production. J. Biol. Chem., 281: 24695\u201324703."},{"key":"10.1194\/jlr.RA120000682_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00500076","article-title":"Lipid and lysosomal enzymes in human fibroblasts cultured with perhexiline maleate","volume":"317","author":"Albouz","year":"1981","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1194\/jlr.RA120000682_bib22","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cmdc.201200306","article-title":"Identification of drugs inducing phospholipidosis by novel in vitro data","volume":"7","author":"Muehlbacher","year":"2012","journal-title":"ChemMedChem."},{"key":"10.1194\/jlr.RA120000682_bib23","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1021\/bi00344a031","article-title":"Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1","volume":"24","author":"Kubo","year":"1985","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.RA120000682_bib24","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/S0021-9258(19)70769-8","article-title":"Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4\u2032-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane","volume":"255","author":"Matsuzawa","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.RA120000682_bib25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0006-2952(81)90451-2","article-title":"Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C","volume":"30","author":"Hostetler","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.RA120000682_bib26","doi-asserted-by":"crossref","unstructured":"Petersen, N. H., O. D., Olsen, L., Groth-Pedersen, A. M., Ellegaard, M., Bilgin, S., Redmer, M. S. Ostenfeld, D. Ulanet, T. H. Dovmark, A. Lonborg, . 2013. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell., 24: 379\u2013393.","DOI":"10.1016\/j.ccr.2013.08.003"},{"key":"10.1194\/jlr.RA120000682_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000315100","article-title":"Small molecule inhibitors of acid sphingomyelinase","volume":"26","author":"Arenz","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1194\/jlr.RA120000682_bib28","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1002\/anie.200903288","article-title":"Potent and selective inhibition of acid sphingomyelinase by bisphosphonates","volume":"48","author":"Roth","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1194\/jlr.RA120000682_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chroma.2016.12.033","article-title":"Assay to measure sphingomyelinase and ceramidase activities efficiently and safely","volume":"1481","author":"M\u00fchle","year":"2017","journal-title":"J. Chromatogr. A."},{"key":"10.1194\/jlr.RA120000682_bib30","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1194\/jlr.D010033","article-title":"A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease","volume":"51","author":"Bedia","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.RA120000682_bib31","doi-asserted-by":"crossref","unstructured":"Kappe, C., Z. H., Mohamed, E., Naser, A., Carpinteiro, and C., Arenz, . A novel visible range FRET probe for monitoring acid sphingomyelinase activity in living cells. Chemistry. Epub ahead of print. February 24, 2020; doi:10.1002\/chem.202000133.","DOI":"10.1002\/chem.202000133"},{"key":"10.1194\/jlr.RA120000682_bib32","doi-asserted-by":"crossref","unstructured":"Gulbins, A., F., Schumacher, K. A., Becker, B., Wilker, M., Soddemann, F., Boldrin, C. P. Muller, M. J. Edwards, M. Goodman, C. C. Caldwell, . 2018. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide. Mol. Psychiatry., 23: 2324\u20132346.","DOI":"10.1038\/s41380-018-0090-9"},{"key":"10.1194\/jlr.RA120000682_bib33","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1194\/jlr.D048132","article-title":"A real-time high-throughput fluorescence assay for sphingosine kinases","volume":"55","author":"Lima","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.RA120000682_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-7-45","article-title":"Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons","volume":"7","author":"Martinez","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1194\/jlr.RA120000682_bib35","doi-asserted-by":"crossref","unstructured":"Voigt, S., S., Philipp, P., Davarnia, S., Winoto-Morbach, C., Roder, C., Arenz, A. Trauzold, D. Kabelitz, S. Sch\u00fctze, H. Kalthoff, . 2014. TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells. BMC Cancer., 14: 74.","DOI":"10.1186\/1471-2407-14-74"},{"key":"10.1194\/jlr.RA120000682_bib36","doi-asserted-by":"crossref","unstructured":"Chung, H. Y., D. C., Hupe, G. P., Otto, M., Sprenger, A. C., Bunck, M. J., Dorer, C. L. Bockmeyer, H. P. Deigner, M. H. Graler, and R. A. Claus. 2016. Acid Sphingomyelinase Promotes Endothelial Stress Response in Systemic Inflammation and Sepsis. Mol. Med., 22: 412\u2013423.","DOI":"10.2119\/molmed.2016.00140"},{"key":"10.1194\/jlr.RA120000682_bib37","doi-asserted-by":"crossref","unstructured":"Sosna, J., S., Philipp, J., Fuchslocher Chico, C., Saggau, J., Fritsch, A., Foll, J. Plenge, C. Arenz. T. Pinkert, A. Trauzold, . 2016. Differences and similarities in TRAIL- and tumor necrosis factor-mediated necroptotic signaling in cancer cells. Mol. Cell. Biol., 36: 2626\u20132644.","DOI":"10.1128\/MCB.00941-15"},{"key":"10.1194\/jlr.RA120000682_bib38","doi-asserted-by":"crossref","unstructured":"McVey, M. J., M., Kim, A., Tabuchi, V., Srbely, L., Japtok, C., Arenz, O. Rotstein, B. Kleuser, J. W. Semple, and W. M. Kuebler. 2017. Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets. Am. J. Physiol. Lung Cell. Mol. Physiol., 312: L625\u2013L637.","DOI":"10.1152\/ajplung.00317.2016"},{"key":"10.1194\/jlr.RA120000682_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates","volume":"264","author":"van Beek","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.RA120000682_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/bbrc.1999.0224","article-title":"Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase\/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo","volume":"255","author":"van Beek","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.RA120000682_bib41","unstructured":"Dunford, J. E., K., Thompson, F. P., Coxon, S. P., Luckman, F. M., Hahn, C. D., Poulter, F. H. Ebetino, and M. J. Rogers. 2001. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J. Pharmacol. Exp. Ther., 296: 235\u2013242."},{"key":"10.1194\/jlr.RA120000682_bib42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1194\/jlr.RA120000682_bib43","doi-asserted-by":"crossref","first-page":"e0173771","DOI":"10.1371\/journal.pone.0173771","article-title":"Lysosomal adaptation: How cells respond to lysosomotropic compounds","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One."},{"key":"10.1194\/jlr.RA120000682_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF03190210","article-title":"The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administration","volume":"15","author":"M\u00f6nkk\u00f6nen","year":"1990","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1194\/jlr.RA120000682_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0300-483X(03)00257-9","article-title":"The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats","volume":"191","author":"Pfister","year":"2003","journal-title":"Toxicology."},{"key":"10.1194\/jlr.RA120000682_bib46","doi-asserted-by":"crossref","unstructured":"Markowitz, G. S., P. L., Fine, J. I., Stack, C. L., Kunis, J., Radhakrishnan, W., Palecki, J. Park, S. H. Nasr, S. Hoh, D. S. Siegel, . 2003. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int., 64: 281\u2013289.","DOI":"10.1046\/j.1523-1755.2003.00071.x"},{"key":"10.1194\/jlr.RA120000682_bib47","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM200310233491721","article-title":"Renal failure with the use of zoledronic acid","volume":"349","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.RA120000682_bib48","doi-asserted-by":"crossref","unstructured":"Klutzny, S., R., Lesche, M., Keck, S., Kaulfuss, A., Schlicker, S., Christian, C. Sperl, R. Neuhaus, J. Mowat, M. Steckel, . 2017. Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death. Cell Death Dis., 8: e2709.","DOI":"10.1038\/cddis.2017.130"},{"key":"10.1194\/jlr.RA120000682_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF02405302","article-title":"The subcellular distribution of [14C]dichloromethylenebisphosphonate and [14C]1-hydroxyethylidene-1,1-bisphosphonate in cultured calvaria cells","volume":"36","author":"Felix","year":"1984","journal-title":"Calcif. Tissue Int."},{"key":"10.1194\/jlr.RA120000682_bib50","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/mol.105.020776","article-title":"Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis","volume":"69","author":"Thompson","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1194\/jlr.RA120000682_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1359\/jbmr.1998.13.2.253","article-title":"Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum","volume":"13","author":"Brown","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1194\/jlr.RA120000682_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone."},{"key":"10.1194\/jlr.RA120000682_bib53","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1124\/dmd.108.021071","article-title":"Biodistribution and plasma protein binding of zoledronic acid","volume":"36","author":"Weiss","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1194\/jlr.RA120000682_bib54","first-page":"473","article-title":"Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats","volume":"20","author":"Lin","year":"1992","journal-title":"Drug Metab. Dispos."},{"key":"10.1194\/jlr.RA120000682_bib55","first-page":"926","article-title":"Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals","volume":"19","author":"Lin","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1194\/jlr.RA120000682_bib56","unstructured":"Donida, B., B., Tauffner, M., Raabe, M. F., Immich, M. A., de Farias, D., de Sa Coutinho, A. Z. Machado, R. G. Kessler, R. V. Portugal, A. Bernardi, . 2018. Monoolein-based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment. Eur. J. Pharm. Biopharm., 133: 96\u2013103."},{"key":"10.1194\/jlr.RA120000682_bib57","doi-asserted-by":"crossref","unstructured":"Beckmann, N., K. A., Becker, S., Kadow, F., Schumacher, M., Kramer, C., Kuhn, W. J. Schulz-Schaeffer, M. J. Edwards, B. Kleuser, E. Gulbins, . 2019. Acid sphingomyelinase deficiency ameliorates Farber disease. Int. J. Mol. Sci., 20: E6253.","DOI":"10.3390\/ijms20246253"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520436004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520436004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.RA120000682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T08:49:33Z","timestamp":1663058973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520436004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0022227520436004"],"URL":"https:\/\/doi.org\/10.1194\/jlr.ra120000682","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.RA120000682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Naser et al.","name":"copyright","label":"Copyright"}]}}